RFQ 36C25724Q0091.pdf

PDF 642 KB Posted

Attached to
6550--New - AMA Urinalysis CPRR IDIQ
Solicitation number
36C25724Q0091
Issued by

About this file

This document is a solicitation for an indefinite delivery/indefinite quantity contract for urinalysis testing services at two Department of Veterans Affairs medical facilities. The solicitation requires vendors to provide fully automated analyzers, reagents, supplies, consumables, maintenance, and training to perform urinary chemistry and microscopic testing. Pricing is fixed price by line item for the base year and four option years. Quotes are due by November 27, 2023. Technical evaluation criteria include equipment dimensions and capabilities, shipment terms, accreditation compliance, and training. Price evaluation will consider total price, option prices, and independent government estimate. The solicitation will result in a single award IDIQ contract with a minimum value of $10,000 and maximum of $550,000 over five years.

View the file

Other files

File Type Posted
36C25724Q0091_1.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

PAGE 1 OF 1. REQUISITION NO.

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NO. 5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

a. NAME b. TELEPHONE NO. (No Collect Calls) 8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY CODE 10. THIS ACQUISITION IS UNRESTRICTED OR SET ASIDE: % FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ IFB RFP

15. DELIVER TO CODE 16. ADMINISTERED BY CODE

17a. CONTRACTOR/OFFEROR CODE FACILITY CODE 18a. PAYMENT WILL BE MADE BY CODE

TELEPHONE NO. UEI: EFT:

PHONE: FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19. 20. 21. 22. 23. 24.

ITEM NO. SCHEDULE OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA 26. TOTAL AWARD AMOUNT (For Govt. Use Only)

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA ARE ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________ 29. AWARD OF CONTRACT: REF. ___________________________________ OFFER

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DATED ________________________________. YOUR OFFER ON SOLICITATION

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION (REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

36C25724Q0091 10-27-2023

Delphia Schoenfeld 210-694-6310 11-27-2023

15:00 EST

36C671

Department Of Veterans Affairs

Network Contracting Office 17

5441 Babcock Road Ste. 302

San Antonio TX 78240

X

325413

1250 Employees

N/A

X

Department of Veterans Affairs

Amarillo VA Healthcare System

Laboratory

6010 Amarillo Blvd.

Amarillo TX 79106

36C671

Network Contracting Office 17

5441 Babcock Road Ste. 302

San Antonio TX 78240

This is accomplished through the

Tungsten Network located at:

http://www.fsc.va.gov/einvoice.asp

This is mandatory and the sole method for submitting invoices.

(877) 353-9791 (512) 460-5540

See CONTINUATION Page

This solicitation is for an Urinalysis CPRR IDIQ for the

Amarillo VA Healthcare System Amarillo and Lubbock Labs.

Refer to Section B.3 for line items required for this IDIQ, Section E.2 concerning the minimum required documentation, and Section E.4 for the evaluation criteria.

See CONTINUATION Page

X X

X 1

Delphia Schoenfeld

Contracting Officer

36C25724Q0091

Table of Contents

SECTION A

A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL

SERVICES

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

B.2 STATEMENT OF WORK

B.3 PRICE/COST SCHEDULE

ITEM INFORMATION

B.4 DELIVERY SCHEDULE

SECTION C - CONTRACT CLAUSES

C.1 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

C.2 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE

ORDERS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (SEP 2023)

C.3 52.216-18 ORDERING (AUG 2020)

C.4 52.216-19 ORDER LIMITATIONS (OCT 1995)

C.5 52.216-22 INDEFINITE QUANTITY (OCT 1995)

C.6 52.217-8 OPTION TO EXTEND SERVICES (NOV 1999)

C.7 VAAR 852.201-70 CONTRACTING OFFICER'S REPRESENTATIVE (DEC 2022)

C.8 VAAR 852.203-70 COMMERCIAL ADVERTISING (MAY 2018)

C.9 VAAR 852.212-71 GRAY MARKET AND COUNTERFEIT ITEMS (FEB 2023)

C.10 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (NOV 2018)

C.11 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020)

C.12 VAAR 852.246-71 REJECTED GOODS (OCT 2018)

C.13 VAAR 852.247-73 PACKING FOR DOMESTIC SHIPMENT (OCT 2018)

SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS

SECTION E - SOLICITATION PROVISIONS

E.1 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB 1998)

E.2 INSTRUCTIONS TO OFFERORS

E.3 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND VIDEO

SURVEILLANCE SERVICES OR EQUIPMENT (NOV 2021)

E.4 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (NOV 2021)

E.5 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (SEP 2023)

E.6 52.233-2 SERVICE OF PROTEST (SEP 2006)

E.7 VAAR 852.215-72 NOTICE OF INTENT TO RE-SOLICIT (OCT 2019)

E.8 VAAR 852.233-70 PROTEST CONTENT/ALTERNATIVE DISPUTE RESOLUTION (OCT 2018)

E.9 VAAR 852.233-71 ALTERNATE PROTEST PROCEDURE (OCT 2018)

E.10 VAAR 852.273-70 LATE OFFERS (NOV 2021)

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:

b. GOVERNMENT: Contracting Officer 36C257

Network Contracting Office 17

5441 Babcock Road Ste. 302

San Antonio TX 78240

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X] 52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or [] 52.232-36, Payment by Third Party

3. INVOICES: Invoices shall be submitted in arrears:

a. Quarterly []

b. Semi-Annually []

c. Other [X] Monthly

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

This is accomplished through the Tungsten Network, located at:

http://ww.fsc.va.gov/einvoice.asp

This is mandatory and the sole method for submitting invoices.

B.2 STATEMENT OF WORK

SCOPE

Amarillo VA Health Care System and its Community Based Outpatient Clinic located in Lubbock, TX, is in need of replacement analyzers to perform Urinalysis testing on our patient population. Our current analyzers contract will be ending 3/31/2024 and a new contract, with instrument validated and ready to run patient samples on

04/01/2024. The vendor shall provide a Cost Per Reportable Result (CPRR) program to include the equipment, service, consumables, reagents, controls, and calibrators necessary to operate system(s). This CPRR program will not include barcodes, tubes, and paper. Training and associated expenses for 2 key operator(s) per instrument is included (training will be used within 12 months of instrument installation).

1. One (1) fully automated analyzer and is identical to the one (1) fully automated analyzer in Lubbock.

Amarillo VA Health Care System Pathology and Laboratory Medicine Service 6010 Amarillo Blvd., West Amarillo, TX 79106

LINE ITEM ITEM Est. Monthly Average Est. Annual Average

0001 Amarillo VAHCS UA CHEMISTRY 2,178 26,136

0002 Amarillo VAHCS MICROSCOPIC 1,089 13,068

2. One (1) fully automated analyzer to be identical to the one (1) fully automated analyzer in Amarillo.

Lubbock VA CBOC Pathology and Laboratory Medicine Service 3510 4th Street Lubbock, TX 79415

LINE ITEM ITEM Est. Monthly Average Est. Annual Average

0001 Lubbock VAHCS UA CHEMISTRY 925 11,100

0002 Lubbock VAHCS MICROSCOPIC 463 5,556

Estimated yearly UA and Microscopic counts for CPRR IDIQ Estimates for AMA and LUB are based on yearly counts over the previous 7 years.

Historically counts have remained consistent; however, counts may increase 1-3% over the next 5 years.

PERFORMANCE PERIOD

IDIQ with five (5) one-year ordering periods:

Ordering Period 1: 1/1/2024-12/31/2024

Ordering Period 2: 1/1/2025-12/31/2025

Ordering Period 3: 1/1/2026-12/31/2026

Ordering Period 4: 1/1/2027-12/31/2027

Ordering Period 5: 1/1/2028-12/31/2028

TYPE OF CONTRACT

1. This is a firm fixed price contract for Indefinite Delivery/Indefinite Quantity (IDIQ) to include all reagents, calibrators, consumables, and service to be delivered upon the ordering facility and/or through metering data usage.

2. The Vendor must provide all equipment, reagents, calibrators, controls, consumable items, parts, accessories, ancillary devices, service plans, shipping costs, installation, validation studies, training, any other item required to establish instrument operation, and should be from the same family of analyzers as applicable and suitable for the facilities listed.

EQUIPMENT REQUIREMENTS

1. Specifications of component equipment as set forth in this section are minimum specifications, unless otherwise stated, and shall not be construed as limiting the overall quality, quantity or performance characteristics of items furnished in the system. The Contractor Furnished Equipment (CFE) shall meet or exceed the minimum requirements and shall be held responsible for the supply, performance, and overall quality of the contractor’s furnished equipment.

2. All equipment to be supplied under this specification shall be the newest and the most current model of a standard product of a manufacturer of record. A manufacturer of record shall be defined as a company whose main occupation is the manufacture for sale of the items of equipment and which:

a. Maintains a factory production line.

b. Maintains a stock of replacement parts for the item.

c. Maintains engineering drawings, specifications, operating manuals, and maintenance manuals.

d. Has published and distributed descriptive literature and equipment specifications on the equipment.

3. Urinalysis equipment must meet the following specifications:

a. The vendor shall provide each facility with Food and Drug Administration (FDA) approved analyzer/equipment, reagents, controls, calibration materials, disposables, and any consumable parts necessary for analyzing/testing. Tests shall be vendor supported. The analyzer must be able to perform all assays listed in section B.3 Price/Cost Schedule.

b. Equipment shall have accurate capability of monitoring reagent usage.

c. The vendor shall provide/install any routine and special items required to operate/maintain the equipment/analyzer in optimal condition such as, but not limited to, printers, UPS, interface boxes and surge suppressors.

d. Must meet performance and characteristics for accuracy and precision as defined by the 1988 Clinical

Laboratory Improvement Act (CLIA) and the Clinical and Laboratory Standards Institute (CLSI).

e. Sufficient capacity to meet the volume and service demands of a minimum of 3000 samples per month.

The analyzer must be able to perform testing on low volume specimens down to 4 mls of sample.

f. Bi-directional, bar-coded computer interface. The fully operational interface (both hardware and software) must be immediately available for implementation to the VA VistA hospital information system/and or Cerner LIS system for real time data transmissions. Interfacing requirements to be provided by the vendor:

i. Instrument LIS physical connection and translation (drivers). Must be compatible with Data

Innovations, Vista, and Cerner Information Systems.

ii. Any additional hardware and software needed to interface the analyzer and technical assistance with interfacing the analyzer

g. The total equipment footprint, when installed, must not negatively impact the functionality/operations of the Pathology & Laboratory Service nor will it require significant and/or costly infrastructure changes. The available space is 50 inches wide X 30 inches deep.

h. Printer must be provided with capability of printing a chartable patient report with the complete patient results on a single sheet.

i. Uninterruptible power supply for the analyzer.

j. Automated sampling system. All analyzers must have primary tube sampling capability and be able to sample directly from aliquot containers and specimen tubes of various sizes with no sample preparation necessary.

k. Analyzer shall have diluting capability with the analyzer calculating the final result.

l. System shall accept urine, and other body fluids.

m. System shall have positive sample identification to reduce possible sources of error/delay and to improve laboratory efficiency.

n. System shall have a design that removes the possibility of reagent or sample carryover, or at the very least have a mechanism in place that notifies the technician of the possible carryover.

i. Carryover studies shall be performed, as applicable, as part of the initial evaluation of the instrument.

ii. Vendor shall provide interpretation of raw data the instrument installed.

iii. Vendor shall also provide documented evidence confirming the system design removes the possibility of any reagent or sample carryover. System must have documented evidence that there is no reagent carryover interference with other onboard assay

o. Must process specimens through all steps so that specimen does not have to be carried by human hands between the components of the analyzer.

p. The analyzers must have a comprehensive QC Program for all tests which includes at a minimum the following options:

i. QC files with automatic calculations of mean and standard deviation of individual lots with data storage.

ii. The ability to view and print daily and monthly QC results

iii. The ability to view and print Levy Jennings graphs

iv. On-line documentation of out-of-range QC

v. QC acceptance criteria built in

q. Equipment shall be able to store and retransmit records (at least 24 hours of maximal instrument throughput) in case of interface downtime. Must have ability to backup and store patient data on external media.

r. Must be able to perform assays listed below without manual confirmation with at least >98% of our samples.

i. GENERAL CHEMISTRY ASSAYS:

A. Glucose B. Protein

C. Bilirubin D. Urobilinogen E. pH F. Blood G. Ketones H. Specific Gravity I. Nitrite J. Leukocyte Esterase K. Color L. Clarity

ii. Microscopic Identifications

A. Red Blood cells B. White Blood cells C. White Blood cell clumps D. Squamous Epithelial cells E. Renal/Transitional Epithelial cells F. Bacteria G. Mucous H. Sperm I. Crystals J. Yeast K. Hyaline casts L. Granular casts M. Cellular casts

s. Vendor shall list the reagents and calibrators that require any additional preparation prior to use such as warming/mixing/reconstitution.

t. Vendor shall list the reagents/waste receptacles requiring treatment before disposal. Vendor shall also list all reagents/waste that is considered above normal toxicity and/or hazard.

u. Remote monitoring, maintenance and/or troubleshooting software that electronically transmits critical operational and administrative information will not be granted.

INSTALLATION AND VALIDATION

1. Vendor shall move instruments, free of charge, to final testing location upon completion of validation process.

a. Due to this procurement occurring during the remodel of the laboratory, Vendor shall move instrument(s), free of charge, to the new laboratory.

b. Should validations be required due to the movement to a new location, the vendor shall perform these as well, free of charge.

2. Vendor shall provide the facility with all cross-over supplies and reagents needed at installation, and during training of staff. Test counts for billing will begin after review/approval of all correlation/linearity studies performed at installation.

3. The vendor shall provide all installation/set-up and when bringing new tests on-line, a technical support specialist who shall perform all validation studies including installation/setup, correlation studies

(evaluation/comparison data sufficient to satisfy CAP standards) normal range studies, staff training, in-services to laboratory personnel and clinicians, and assist with any methodology problems and questions. This service shall be available during regular office hours (0800-1700) on a 5 days/week basis.

4. Throughout the life of the agreement, the vendor shall provide assistance to the user with setup, maintenance, and troubleshooting user-defined assays as additional tests are identified and utilized.

TRAINING

1. The vendor shall provide key operator training for a minimum of two users per instrument with on-site training available to remaining users on all tours with competency assessment performed and documented.

Key operators training shall be arranged by the vendor and include all costs of off-site training, i.e., transportation (air and ground), room and board, etc.

2. Vendor shall provide/install/train users on any data management system with either off site or in house training.

3. Vendor shall provide all necessary procedure manuals, troubleshooting manuals and operator manuals (also available on computer disk format). Procedures shall be in the Clinical and Laboratory Standards Institute

(CLSI) format.

BILLING AND INVOICING

1. Monthly billing and test report summaries shall begin on the first day of the month and include the last day of the month.

2. VA-FSC shall require the following information in compliance with the Prompt Pay Act and Business

Requirements.

a. Your Taxpayer ID number (TIN)

b. Your “Remit Address” information

c. The VA Purchase Order (PO) number

d. Your contact information: (Personal name, Email, and Phone)

e. Your VA Point of contact information (Personal name, Email, and Phone)

f. The Period of Performance dates (POP Beginning and Ending)

g. All discount information if applicable (Percent and Date Terms)

h. Reagents used with pricing per unit

i. No freight charges to be added to the invoice

3. AVAHCS shall not be responsible for payment of services and or supplies which were not requested in accordance with the contract.

4. AVAHCS will NOT pay for tests that are not clearly identified by product number on the invoice.

5. AVAHCS shall not be charged for replacement of reagents, supplies, and consumables received at the Amarillo and Lubbock Laboratories outside of the acceptable temperature r.

6. Invoices are to be separate for Amarillo and Lubbock laboratories, but the usage of the same PO number is acceptable for billing purposes.

7. All invoices submitted through Tungsten to VA-FSC should mirror your current submission of Invoice and shall match final contract pricing.

HOURS OF OPERATION

1. Normal hours of operations at the VAMC are Monday through Friday from 8:00 am to 4:30 pm, excluding holidays.

2. All work will be performed during normal hours of coverage unless requested or approved by Chemistry

Supervisor or his designee.

3. Federal Holidays observed by the VAMC are:

New Years' Day Martin Luther King Day Presidents' Day Memorial Day Juneteenth Independence Day Labor Day Columbus Day Veterans’ Day Thanksgiving Day Christmas Day

4. Equipment repair response time shall be no more than 24 hours.

5. Preventative maintenance will be performed as frequently as published in manufacturer’s operator’s manual and within 2 weeks of the scheduled due date.

6. A malfunction incident report shall be furnished upon completion of each repair call. The report shall include, at minimum, the following: date and time notified, date and time of arrival, serial number, type and model number of equipment, time spent for repair, and proof of repair to include documentation of a sample run of quality control verifying acceptable performance.

7. Each notification for an emergency repair service call shall be treated as a separate and new service call.

8. Support shall include remote management software including diagnostics for equipment. Remote access to equipment is not available at this time.

9. Vendor shall not access patient information during service and/or repairs.

SERVICE AND MAINTENANCE

1. Instrument support service shall aid with troubleshooting and repair of the analyzers. On-site service shall be available Monday through Friday during regular business hours (8am-5pm). The support service shall follow-up all down time calls within 1 hour.

2. The vendor shall provide a twenty-four hour/seven-day service hotline with technical support.

3. The vendor shall provide a preventative maintenance schedule to include timely scheduled vendor preventative maintenance visits as required.

4. The vendor shall supply engineering controls if necessary for any heat, humidity, or noise issues that may result from use of the proposed system.

5. Vendor shall provide standard and routine software and hardware upgrades to the equipment hardware and operating systems, without additional charge to the Government (e.g., upgrades that correct or improve either the mechanical operations or software of the system and would keep the instrument performing optimally).

6. Vendor shall define daily, weekly, monthly, and as needed maintenance and the time required to perform each maintenance task. Vendor shall indicate which tasks are user level and which are service level.

7. For reagents with hazardous constituents, vendor shall provide a mechanism for the Laboratory to meet local discharge requirements. The vendor shall supply information regarding any hazardous chemicals.

INTERFACE

1. Transfer of data is bidirectional and will occur in the following manner:

2. The following data fields will be collected:

a. Prime ID b. Specimen ID c. Patient ID

d. Priority e. Action code f. Sample type

g. Collect date h. Collect time i. Creation date

j. Creation time k. Last name l. First name

m. Middle name n. Sex o. Birthday

p. Location q. Analyzer r. Station

s. Test name

3. Data is transferred from VISTA to a Data Innovations Middleware (DI) device which is then sent to the instrument, using the appropriate format. Once testing is complete, the instrument sends the result back to the DI which then sends the result back to VISTA in the appropriate format.

4. All testing is performed by Pathology & Laboratory Medicine Service staff using appropriate procedures, access and verify codes. VA sensitive information is stored in the VISTA/LIS database and all records are backed up on disk and stored in a secure, location, (disks in locked drawers behind locked doors) per regulations. Data will be available to providers using CPRS system.

5. The above Personal Private Information (PPI) will stay on the instrument’s hard drive for about one month and then will be “written” over by new patient data. At the end of the contract the hard drive and any other data storing devices will be removed from the instrument and be taken to IRM for disposal.

OTHER

1. Request for instrumentation upgrades or replacement due to workload increase, excessive instrumentation failures/malfunctions, breakdowns, or service calls shall be evaluated as needed/annually by the laboratory with communication to the vendor for modification of the order. A high incidence of such problems with any equipment/analyzer supplied may indicate probable non-compliance with the terms of this contract and will entitle the facility/clinic to its replacement with other analyzer(s) that can produce the required criteria satisfactorily to the user.

2. The vendor shall remove all equipment within 90 days after notification of the expiration of the terms of this agreement but not until the completion of new vendor's equipment installation inclusive of completed cross over studies. Vendor shall be responsible for removing the hard drive and turning it over to the VA for destruction prior to removal of any analyzer.

VISTA

(LIS)

DATA

INNOVATIONS

INSTRUMENT

3. The vendor shall reimburse the facility for any costs/supplies related to tests sent to a referral laboratory when testing is not available through no fault of the facility due to reagent problems, other product issues, or other vendor related factors. The assessed damages shall be applied to the invoice in the form of a credit or deduction.

4. If the any consumable, reagent, or other necessary item are found to be defective and unsuitable for use with the vendor's equipment, or the contractor has failed to comply with the requirements for routine supply delivery, the contractor shall deliver the consumable supplies within a period of 24 hours after receipt of the verbal order for priority delivery from the facility. If either circumstance has occurred, the vendor shall deliver to the facility, in the most expeditious manner possible, without additional cost to the facility, the necessary consumables in sufficient quantity so testing is not delayed.

5. This order should assist the Department of Veterans Affairs to pursue the goal of being a good steward in our community by eliminating, minimizing, or mitigating adverse environmental impacts.

6. There following chemicals have been targeted by the EPA specifically for reductions and feasible elimination.

Please list any reagents (and in what concentration) that contain the following chemicals:

1,1,1-Trichloro-ethane Benzene Cadmium Carbon tetrachloride Chloroform Chromium Cyanide Dichloromethane Lead Mercury Methyl ethyl ketone Methyl isobutyl ketone Nickel Tetrachloro-ethylene Toluene Trichloro-ethylene Xylenes

COMPLIANCE WITH THE GENERAL SAFETY REGULATIONS

1. All Contractors and Subcontractors performing services for the Government shall comply with all Occupational

Safety and Health Administration (OSHA), State, County and Municipal Safety and Occupational Health Standards and any other applicable rules and regulations. Also, all Contractors and Subcontractors shall be held responsible for the safety of their employees and any unsafe acts or conditions that may cause injury or damage to any persons or property within and around the work site area under this contract.

2. All ladders, scaffolding, tools, equipment, personal protective equipment, etc. shall be OSHA approved for the work to be performed. Contractor shall use caution signs as required by OSHA Regulations. Caution signs shall be on-site on commencement of Contract.

3. The Contractor shall purchase and issue all chemicals in their original containers. Materials that require precautionary warnings shall have affixed to all containers such labels or markings as are prescribed by law, regulatory agencies or this Contract. Any violation of OSHA may be subject to default action.

4. Contractor shall furnish to the COR two (2) copies of Safety Data Sheets (SDS), for all products proposed for use, a minimum of seven (7) days prior to beginning service, for approval. Contractor must update copies of the SDS on an annual basis. In addition, each time a new chemical product is proposed to be introduced into the facility, a copy of that product's SDS must be provided to the COR for approval, prior to the product being used at the facility.

IDENTIFICATION, PARKING, SMOKING, AND VA REGULATIONS:

1. The Contractor's FSEs shall wear visible identification at all times while on the premises of the VAMC. It is the responsibility of the contractor to obtain and pay for parking. The VAMC does not provide any parking. The

VAMC will not invalidate or make reimbursement for parking violations or charges for the Contractor under any conditions. Smoking is prohibited inside any buildings at the VAMC.

2. Possession of weapons is prohibited. Enclosed containers, including tool kits, shall be subject to search.

Violations of VA regulations may result in citation answerable in the United States (Federal) District Court, not a local district, state, or municipal court.

CONFIDENTIALITY AND NONDISCLOSURE

It is agreed that:

1. The preliminary and final deliverables, and all associated working papers, application source code, and other material deemed relevant by VA which have been generated by the Vendor in the performance of this task order, are the exclusive property of the U.S. Government and shall be submitted to the CO at the conclusion of the task order.

2. The CO will be the sole authorized official to release, verbally or in writing, any data, draft deliverables, final deliverables, or any other written or printed materials pertaining to this task order. No information shall be released by the Vendor Any request for information relating to this task order, presented to the contractor, shall be submitted to the CO for response.

3. Press releases, marketing material, or any other printed or electronic documentation related to this project, shall not be publicized without the written approval of the CO.

CONTRACTOR SECURITY REQUIREMENTS

1. The Vendor requires no access to AVAHCS or any VA information system. The Vendors analyzers will be compatible and interfaced to the AVAHCS information system. There will be supervised access when the

Vendor is physically present for technical support, service calls, and scheduled preventative maintenance.

2. NO VA DATA OF ANY TYPE SHALL BE TRANSFERRED FROM THE VA.

3. The C&A requirements do not apply. A Security Accreditation Package is not required.

RECORDS MANAGEMENT

1. All records (administrative and program specific for AMA/LUB) created during the period of the contract belongs to AVAHCS and must be returned to AVAHCS at the end of the contract.

B.3 PRICE/COST SCHEDULE

This is Single Award, Firm Fixed-Price, Indefinite Delivery Indefinite Quantity (IDIQ) Contract.

The guaranteed minimum award amount for this contract is $10,000.00. The maximum aggregate value of orders that can be placed under this contract is $550,000.00. The Government does not guarantee that it will place any orders in excess of the guaranteed minimum award amount.

Ordering Period 1: 1/1/2024 – 12/31/2024 Ordering Period 2: 1/1/2025 – 12/31/2025 Ordering Period 3: 1/1/2026 – 12/31/2026 Ordering Period 4: 1/1/2027 – 12/31/2027 Ordering Period 5: 1/1/2028 – 12/31/2028

ITEM INFORMATION

ITEM

NUMBER

DESCRIPTION OF

SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

0.00 YR __________________ __________________

Amarillo Testing

Includes Equipment, Reagents, Supplies, Consumables, and Maintenance Contract Period: Base POP Begin: 01-01-2024 POP End: 12-31-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets Amarillo VA Healthcare System Urinalysis CPRR

0001AA

26,136.00 EA __________________ __________________

Amarillo Urinalysis Chemistry

Contract Period: Base POP Begin: 01-01-2024

POP End: 12-31-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

0001AB

13,068.00 EA __________________ __________________

Amarillo Microscopic

Contract Period: Base POP Begin: 01-01-2024 POP End: 12-31-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Lubbock Testing

Includes Equipment, Reagents, Supplies, Consumables, and Maintenance Contract Period: Base POP Begin: 01-01-2024 POP End: 12-31-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 0002AA

11,100.00 EA __________________ __________________

Lubbock Urinalysis Chemistry

Contract Period: Base POP Begin: 01-01-2024 POP End: 12-31-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 0002AB

5,556.00 EA __________________ __________________

Lubbock Microscopic

Contract Period: Base POP Begin: 01-01-2024 POP End: 12-31-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Includes Equipment, Reagents, Supplies, Consumables, and Maintenance Contract Period: Option 1 POP Begin: 01-01-2025 POP End: 12-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

1001AA

Contract Period: Option 1 POP Begin: 01-01-2025 POP End: 12-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 1001AB

Contract Period: Option 1 POP Begin: 01-01-2025 POP End: 12-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Includes Equipment, Reagents, Supplies, Consumables, and Maintenance Contract Period: Option 1 POP Begin: 01-01-2025 POP End: 12-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 1002AA

Contract Period: Option 1 POP Begin: 01-01-2025 POP End: 12-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 1002AB

Contract Period: Option 1 POP Begin: 01-01-2025 POP End: 12-31-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Includes Equipment, Reagents, Supplies, Consumables, and Maintenance Contract Period: Option 2 POP Begin: 01-01-2026 POP End: 12-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 2001AA

Contract Period: Option 2 POP Begin: 01-01-2026 POP End: 12-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 2001AB

Contract Period: Option 2 POP Begin: 01-01-2026 POP End: 12-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Includes Equipment, Reagents, Supplies, Consumables, and Maintenance Contract Period: Option 2 POP Begin: 01-01-2026 POP End: 12-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 2002AA

Contract Period: Option 2 POP Begin: 01-01-2026 POP End: 12-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 2002AB

Contract Period: Option 2 POP Begin: 01-01-2026

POP End: 12-31-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

Includes Equipment, Reagents, Supplies, Consumables, and Maintenance Contract Period: Option 3 POP Begin: 01-01-2027 POP End: 12-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 3001AA

Contract Period: Option 3 POP Begin: 01-01-2027 POP End: 12-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 3001AB

Contract Period: Option 3 POP Begin: 01-01-2027 POP End: 12-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Includes Equipment, Reagents, Supplies, Consumables, and Maintenance Contract Period: Option 3 POP Begin: 01-01-2027 POP End: 12-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 3002AA

Contract Period: Option 3 POP Begin: 01-01-2027 POP End: 12-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Test Kits and Sets

3002AB

Contract Period: Option 3 POP Begin: 01-01-2027 POP End: 12-31-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Includes Equipment, Reagents, Supplies, Consumables, and Maintenance Contract Period: Option 4 POP Begin: 01-01-2028 POP End: 12-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 4001AA

Contract Period: Option 4 POP Begin: 01-01-2028 POP End: 12-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 4001AB

Contract Period: Option 4 POP Begin: 01-01-2028 POP End: 12-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Includes Equipment, Reagents, Supplies, Consumables, and Maintenance Contract Period: Option 4 POP Begin: 01-01-2028 POP End: 12-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4002AA

Contract Period: Option 4 POP Begin: 01-01-2028 POP End: 12-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, 4002AB

Contract Period: Option 4 POP Begin: 01-01-2028 POP End: 12-31-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, GRAND TOTAL __________________

B.4 DELIVERY SCHEDULE

Amarillo VA Health Care System Pathology and Laboratory Medicine Service 6010 Amarillo Blvd., West Amarillo, TX 79106

Lubbock VA CBOC Pathology and Laboratory Medicine Service 3510 4th Street Lubbock, TX 79415

SECTION C - CONTRACT CLAUSES

C.1 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es):

https://www.acquisition.gov/browse/index/far https://www.va.gov/oal/library/vaar/

(End of Clause)

FAR Number Title Date

52.203-17 CONTRACTOR EMPLOYEE WHISTLEBLOWER RIGHTS AND REQUIREMENT

TO INFORM EMPLOYEES OF WHISTLEBLOWER RIGHTS

JUN 2020

52.204-4 PRINTED OR COPIED DOUBLE-SIDED ON POSTCONSUMER FIBER

CONTENT PAPER

MAY 2011

52.204-13 SYSTEM FOR AWARD MANAGEMENT MAINTENANCE OCT 2018

52.204-18 COMMERCIAL AND GOVERNMENT ENTITY CODE MAINTENANCE AUG 2020

52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES

DEC 2022

52.237-3 CONTINUITY OF SERVICES JAN 1991

C.2 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT

STATUTES OR EXECUTIVE ORDERS—COMMERCIAL PRODUCTS AND COMMERCIAL

SERVICES (SEP 2023)

(a) The Contractor shall comply with the following Federal Acquisition Regulation (FAR) clauses, which are incorporated in this contract by reference, to implement provisions of law or Executive orders applicable to acquisitions of commercial products and commercial services:

(1) 52.203-19, Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (JAN 2017)

(section 743 of Division E, Title VII, of the Consolidated and Further Continuing Appropriations Act, 2015 (Pub. L.

113-235) and its successor provisions in subsequent appropriations acts (and as extended in continuing resolutions)).

(2) 52.204–23, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by

Kaspersky Lab and Other Covered Entities (NOV 2021) (Section 1634 of Pub. L. 115–91).

(3) 52.204–25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or

Equipment. (NOV 2021) (Section 889(a)(1)(A) of Pub. L. 115–232).

(4) 52.209-10, Prohibition on Contracting with Inverted Domestic Corporations (NOV 2015).

(5) 52.232–40, Providing Accelerated Payments to Small Business Subcontractors (MAR 2023) (31 U.S.C. 3903 and 10 U.S.C. 3801).

(6) 52.233-3, Protest After Award (AUG 1996) (31 U.S.C. 3553).

(7) 52.233-4, Applicable Law for Breach of Contract Claim (OCT 2004) (Public Laws 108-77 and 108-78 (19 U.S.C.

3805 note)).

(b) The Contractor shall comply with the FAR clauses in this paragraph (b) that the Contracting Officer has indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial products and commercial services:

[X] (1) 52.203–6, Restrictions on Subcontractor Sales to the Government (JUN 2020), with Alternate I (NOV

2021) (41 U.S.C. 4704 and 10 U.S.C. 4655).

[] (2) 52.203–13, Contractor Code of Business Ethics and Conduct (NOV 2021) (41 U.S.C. 3509).

[] (3) 52.203–15, Whistleblower Protections under the American Recovery and Reinvestment Act of 2009 (JUN

2010) (Section 1553 of Pub. L. 111-5). (Applies to contracts funded by the American Recovery and Reinvestment

Act of 2009.)

[X] (4) 52.204–10, Reporting Executive Compensation and First-Tier Subcontract Awards (JUN 2020) (Pub. L.

109–282) (31 U.S.C. 6101 note).

[] (5) [Reserved]

[] (6) 52.204–14, Service Contract Reporting Requirements (OCT 2016) (Pub. L. 111–117, section 743 of Div. C).

[] (7) 52.204–15, Service Contract Reporting Requirements for Indefinite-Delivery Contracts (OCT 2016) (Pub. L.

111–117, section 743 of Div. C).

[X] (8) 52.204–27, Prohibition on a ByteDance Covered Application (JUN 2023) (Section 102 of Division R of Pub.

L. 117–328).

[X] (9) 52.209–6, Protecting the Government’s Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment. (NOV 2021) (31 U.S.C. 6101 note).

[] (10) 52.209-9, Updates of Publicly Available Information Regarding Responsibility Matters (OCT 2018) (41

U.S.C. 2313).

[] (11) [Reserved]

[] (12) 52.219–3, Notice of HUBZone Set-Aside or Sole-Source Award (OCT 2022) (15 U.S.C. 657a).

[X] (13) 52.219–4, Notice of Price Evaluation Preference for HUBZone Small Business Concerns (OCT 2022) (if the offeror elects to waive the preference, it shall so indicate in its offer) (15 U.S.C. 657a).

[] (14) [Reserved]

[] (15)(i) 52.219-6, Notice of Total Small Business Set-Aside (NOV 2020) (15 U.S.C. 644).

[] (ii) Alternate I (MAR 2020) of 52.219-6.

[] (16)(i) 52.219-7, Notice of Partial Small Business Set-Aside (NOV 2020) (15 U.S.C. 644).

[] (ii) Alternate I (MAR 2020) of 52.219-7.

[X] (17) 52.219-8, Utilization of Small Business Concerns (SEP 2023) (15 U.S.C. 637(d)(2) and (3)).

[] (18)(i) 52.219–9, Small Business Subcontracting Plan (SEP 2023) (15 U.S.C. 637(d)(4)).

[] (ii) Alternate I (NOV 2016) of 52.219-9.

[] (iii) Alternate II (NOV 2016) of 52.219-9.

[] (iv) Alternate III (JUN 2020) of 52.219–9.

[] (v) Alternate IV (SEP 2023) of 52.219–9.

[] (19)(i) 52.219-13, Notice of Set-Aside of Orders (MAR 2020) (15 U.S.C. 644(r)).

[] (ii) Alternate I (MAR 2020) of 52.219-13.

[] (20) 52.219–14, Limitations on Subcontracting (OCT 2022) (15 U.S.C. 657s).

[] (21) 52.219-16, Liquidated Damages—Subcontracting Plan (SEP 2021) (15 U.S.C. 637(d)(4)(F)(i)).

[] (22) 52.219–27, Notice of Service-Disabled Veteran-Owned Small Business Set-Aside (OCT 2022) (15 U.S.C.

657f).

[X] (23) (i) 52.219–28, Post-Award Small Business Program Rerepresentation (SEP 2023) (15 U.S.C. 632(a)(2)).

[] (ii) Alternate I (MAR 2020) of 52.219–28.

[] (24) 52.219–29, Notice of Set-Aside for, or Sole-Source Award to, Economically Disadvantaged Women-

Owned Small Business Concerns (OCT 2022) (15 U.S.C. 637(m)).

[] (25) 52.219–30, Notice of Set-Aside for, or Sole-Source Award to, Women-Owned Small Business Concerns

Eligible Under the Women-Owned Small Business Program (OCT 2022) (15 U.S.C. 637(m)).

[] (26) 52.219-32, Orders Issued Directly Under Small Business Reserves (MAR 2020) (15 U.S.C. 644(r)).

[] (27) l(26) 52.219–33, Nonmanufacturer Rule (SEP 2021) (15 U.S.C. 657s).

[X] (28) 52.222-3, Convict Labor (JUN 2003) (E.O. 11755).

[X] (29) 52.222–19, Child Labor—Cooperation with Authorities and Remedies (DEC 2022) (E.O. 13126).

[X] (30) 52.222-21, Prohibition of Segregated Facilities (APR 2015).

[X] (31)(i) 52.222–26, Equal Opportunity (SEP 2016) (E.O. 11246).

[] (ii) Alternate I (FEB 1999) of 52.222-26.

[X] (32)(i) 52.222–35, Equal Opportunity for Veterans (JUN 2020) (38 U.S.C. 4212).

[] (ii) Alternate I (JUL 2014) of 52.222-35.

[X] (33)(i) 52.222–36, Equal Opportunity for Workers with Disabilities (JUN 2020) (29 U.S.C. 793).

[] (ii) Alternate I (JUL 2014) of 52.222-36.

[X] (34) 52.222–37, Employment Reports on Veterans (JUN 2020) (38 U.S.C. 4212).

[X] (35) 52.222-40, Notification of Employee Rights Under the National Labor Relations Act (DEC 2010) (E.O.

13496).

[X] (36)(i) 52.222-50, Combating Trafficking in Persons (NOV 2021) (22 U.S.C. chapter 78 and E.O. 13627).

[] (ii) Alternate I (MAR 2015) of 52.222-50 (22 U.S.C. chapter 78 and E.O. 13627).

[] (37) 52.222-54, Employment Eligibility Verification (MAY 2022). (E. O. 12989). (Not applicable to the acquisition of commercially available off-the-shelf items or certain other types of commercial products or commercial services as prescribed in FAR 22.1803.)

[] (38)(i) 52.223-9, Estimate of Percentage of Recovered Material Content for EPA-Designated Items (MAY 2008)

(42 U.S.C.6962(c)(3)(A)(ii)). (Not applicable to the acquisition of commercially available off-the-shelf items.)

[] (ii) Alternate I (MAY 2008) of 52.223-9 (42 U.S.C. 6962(i)(2)(C)). (Not applicable to the acquisition of commercially available off-the-shelf items.)

[] (39) 52.223-11, Ozone-Depleting Substances and High Global Warming Potential Hydrofluorocarbons (JUN

2016) (E.O. 13693).

[] (40) 52.223-12, Maintenance, Service, Repair, or Disposal of Refrigeration Equipment and Air Conditioners

(JUN 2016) (E.O. 13693).

[] (41)(i) 52.223-13, Acquisition of EPEAT®-Registered Imaging Equipment (JUN 2014) (E.O.s 13423 and 13514).

[] (ii) Alternate I (OCT 2015) of 52.223-13.

[] (42)(i) 52.223-14, Acquisition of EPEAT®-Registered Televisions (JUN 2014) (E.O.s 13423 and 13514).

[] (ii) Alternate I (JUN 2014) of 52.223-14.

[] (43) 52.223-15, Energy Efficiency in Energy-Consuming Products (MAY 2020) (42 U.S.C. 8259b).

[] (44)(i) 52.223-16, Acquisition of EPEAT®-Registered Personal Computer Products (OCT 2015) (E.O.s 13423 and

13514).

[] (ii) Alternate I (JUN 2014) of 52.223-16.

[X] (45) 52.223–18, Encouraging Contractor Policies to Ban Text Messaging While Driving (JUN 2020) (E.O.

13513).

[] (46) 52.223-20, Aerosols (JUN 2016) (E.O. 13693).

[] (47) 52.223-21, Foams (JUN 2016) (E.O. 13693).

[] (48)(i) 52.224-3, Privacy Training (JAN 2017) (5 U.S.C. 552a).

[] (ii) Alternate I (JAN 2017) of 52.224-3.

[] (49)(i) 52.225-1, Buy American—Supplies (OCT 2022) (41 U.S.C. chapter 83).

[] (ii) Alternate I (OCT 2022) of 52.225–1.

[] (50)(i) 52.225-3, Buy American—Free Trade Agreements—Israeli Trade Act (DEC 2022) (19 U.S.C. 3301 note, 19 U.S.C. 2112 note, 19 U.S.C. 3805 note, 19 U.S.C. 4001 note, 19 U.S.C. chapter 29 (sections 4501-4732), Public

Law 103-182, 108-77, 108-78, 108-286, 108-302, 109-53, 109-169, 109-283, 110-138, 112-41, 112-42, and 112-43.

[] (ii) Alternate I [Reserved].

[] (iii) Alternate II (DEC 2022) of 52.225-3.

[] (iv) Alternate III (JAN 2021) of 52.225-3.

[] (v) Alternate IV (OCT 2022) of 52.225-3.

[X] (51) 52.225–5, Trade Agreements (DEC 2022) (19 U.S.C. 2501, et seq., 19 U.S.C. 3301 note).

[X] (52) 52.225-13, Restrictions on Certain Foreign Purchases (FEB 2021) (E.O.'s, proclamations, and statutes administered by the Office of Foreign Assets Control of the Department of the Treasury).

[] (53) 52.225–26, Contractors Performing Private Security Functions Outside the United States (OCT 2016)

(Section 862, as amended, of the National Defense Authorization Act for Fiscal Year 2008; 10 U.S.C. Subtitle A, Part

V, Subpart G Note).

[] (54) 52.226-4, Notice of Disaster or Emergency Area Set-Aside (NOV 2007) (42 U.S.C. 5150).

[] (55) 52.226-5, Restrictions on Subcontracting Outside Disaster or Emergency Area (NOV 2007) (42 U.S.C.

5150).

[X] (56) 52.229–12, Tax on Certain Foreign Procurements (FEB 2021).

[] (57) 52.232-29, Terms for Financing of Purchases of Commercial Products and Commercial Services (NOV

2021) (41 U.S.C. 4505, 10 U.S.C. 3805).

[] (58) 52.232-30, Installment Payments for Commercial Products and Commercial Services (NOV 2021) (41

U.S.C. 4505, 10 U.S.C. 3805).

[X] (59) 52.232-33, Payment by Electronic Funds Transfer—System for Award Management (OCT 2018) (31

U.S.C. 3332).

[] (60) 52.232-34, Payment by Electronic Funds Transfer—Other than System for Award Management (JUL 2013)

(31 U.S.C. 3332).

[] (61) 52.232-36, Payment by Third Party (MAY 2014) (31 U.S.C. 3332).

[] (62) 52.239-1, Privacy or Security Safeguards (AUG 1996) (5 U.S.C. 552a).

[] (63) 52.242-5, Payments to Small Business Subcontractors (JAN 2017)(15 U.S.C. 637(d)(13)).

[] (64)(i) 52.247-64, Preference for Privately Owned U.S.-Flag Commercial Vessels (NOV 2021) (46 U.S.C. 55305 and 10 U.S.C. 2631).

[] (ii) Alternate I (APR 2003) of 52.247-64.

[] (iii) Alternate II (NOV 2021) of 52.247-64.

(c) The Contractor shall comply with the FAR clauses in this paragraph (c), applicable to commercial services, that the Contracting Officer has indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial products and commercial services:

[] (1) 52.222-41, Service Contract Labor Standards (AUG 2018) (41 U.S.C. chapter 67).

[] (2) 52.222-42, Statement of Equivalent Rates for Federal Hires (MAY 2014) (29 U.S.C. 206 and 41 U.S.C.

chapter 67).

[] (3) 52.222-43, Fair Labor Standards Act and Service Contract Labor Standards—Price Adjustment (Multiple

Year and Option Contracts) (AUG 2018) (29 U.S.C. 206 and 41 U.S.C. chapter 67).

[] (4) 52.222-44, Fair Labor Standards Act and Service Contract Labor Standards—Price Adjustment (MAY 2014)

(29 U.S.C 206 and 41 U.S.C. chapter 67).

[X] (5) 52.222-51, Exemption from Application of the Service Contract Labor Standards to Contracts for

Maintenance, Calibration, or Repair of Certain Equipment—Requirements (MAY 2014) (41…

This is the start of the file's text. The full file is on GovTribe.

File details come from the government source that posted it. Updated .